GEFCO’s Air & Sea business has announced new leadership and a reorganisation to boost customer-centricity and accelerate business in three key sectors: industry, automotive and life science/healthcare. Since February, Paul-Henri Fréret, Executive Vice President has been leading GEFCO’s Air & Sea division. Paul-Henri has managed all areas of the business in Asia and Latin America in addition to Groupe PSA operations at Group headquarters and held global corporate management functions at GEFCO in warehouse logistics and road transport.
In May, Cyril Lefebvre was promoted to Global Sales and Marketing Director for the Air & Sea division, from Managing Director of French operations. With experience in Air & Sea operations at GEFCO and other Freight Forwarding companies, Cyril is hoped to shape and drive the division’s commercial and marketing strategy worldwide.
Air & Sea has also reinforced its organisation to drive business in three key sectors: industry, automotive and life sciences/healthcare. Serge Kisselevsky is now Industry Market Line Manager, while Adrian Draghici is Market Line Manager for Automotive. Karin Van-Den Brekel will continue to lead the Life Science and Healthcare business, a role she has occupied since 2019.
Since the start of the COVID-19 epidemic, GEFCO’s Air & Sea Division has deployed its Time Critical solutions to help keep customers’ supply chains moving. For two European automotive players, GEFCO handled shipments of 750 tonnes of key automotive spare parts from China to France, including turbo compressors, pistons, control panels and doors in eight chartered flights to prevent production stoppages. For a global medical diagnostics firm, GEFCO transported 30 tonnes of medical equipment, including COVID-19 testing kits, from France to destinations in Algeria, Tunisia and the Antilles to help hospitals and private laboratories manage increased demand. Similarly, GEFCO transported around 1,000 medical beds weekly to destinations across Europe for a European manufacturer of medical devices and surgical equipment to cope with high demand for medical beds and devices during the COVID-19 crisis.
Source: GEFCO
